| P2093 | author name string | Banu K Arun | |
| | Jennifer K Litton | |
| | Kaylene Ready | |
| P2860 | cites work | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 |
| | Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 |
| | Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 |
| | American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography | Q28295438 |
| | Characterization of BRCA1 and BRCA2 mutations in a large United States sample | Q28383993 |
| | Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 |
| | Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics | Q31152672 |
| | A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes | Q34115258 |
| | Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation | Q34129784 |
| | Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations | Q34129787 |
| | Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 | Q34384153 |
| | BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families | Q34480647 |
| | Cancer risks in BRCA2 mutation carriers | Q34504452 |
| | Cancer Incidence in BRCA1 mutation carriers | Q34527264 |
| | Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme | Q35441054 |
| | A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO | Q35445946 |
| | Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history | Q35895179 |
| | Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors | Q35986971 |
| | Risk prediction models for familial breast cancer | Q36430753 |
| | Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States | Q37155632 |
| | Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model | Q37246495 |
| | Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry | Q37252756 |
| | Accuracy of the BRCAPRO model among women with bilateral breast cancer | Q37363896 |
| | Projecting individualized absolute invasive breast cancer risk in African American women | Q40149673 |
| | Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations | Q43073772 |
| | The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. | Q43974233 |
| | Cancer risk prediction models: a workshop on development, evaluation, and application | Q44065523 |
| | Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals | Q46796026 |
| | Validation of the Gail et al. model for predicting individual breast cancer risk. | Q50603613 |
| | A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 |
| | Assessing BRCA carrier probabilities in extended families. | Q52997805 |
| | Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. | Q53409967 |
| | Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. | Q54645721 |
| | BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes | Q57309394 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | risk assessment model | Q117383677 |
| P304 | page(s) | 355-365 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Clinical application of breast cancer risk assessment models | |
| P478 | volume | 6 | |